Search

Your search keyword '"I. Chau"' showing total 477 results

Search Constraints

Start Over You searched for: Author "I. Chau" Remove constraint Author: "I. Chau"
477 results on '"I. Chau"'

Search Results

1. P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

2. BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

7. O-3 Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648

8. 1205MO Updated analysis of DESTINY-Gastric02: A phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable/metastatic gastric/gastroesophageal junction (GEJ) cancer who progressed on or after trastuzumab-containing regimen

9. 633P Determining the prognostic value of end of treatment (EOT) 18F-choline positron emission tomography (PET) in patients treated with primary central nervous system lymphoma (PCNSL) who respond to first-line therapy: A single centre retrospective study at the Royal Marsden Hospital (RMH)

11. PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma

13. 1386P Phase II study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (pembro) in advanced gastric or gastroesophageal junction (GEJ) cancer

15. Caregiving burden among informal caregivers of people with disability

16. Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies

17. Gastric Cancer - From Aetiology to Management: Differences Between the East and the West

19. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

20. Quality-of-life (QoL) results from RAINFALL: A randomized, double-blind, placebo (PL)-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy for metastatic gastric or gastroesophageal junction (G-GEJ) cancer

21. The lateral load-deformation response of RC walls with a consideration of the height–length ratio

22. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis

23. Life-cycle cost analysis in determining an importance factor for fire department buildings

24. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer

25. Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer

26. MORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

27. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)

28. EGFR amplification (amp) and survival in the REAL-3 trial

29. Application of Normalized Spectral Acceleration-Displacement (NSAD) Format on Performance-Based Seismic Design of Bridge Structures

30. The Timed-up-and-go (TUG) Test: Illustrative Case Presentation to Demonstrate Its Relation to Pain, Functional Disability, and Health-Related Quality of Life in Patients with Lumbar Degenerative Disc Disease

31. Correlation of Pain, Functional Disability, and Health-Related Quality of Life with Radiological Grading Scales for Lumbar Degenerative Disc Disease

33. Validity and Reliability of an Objective Measurement of Functional Impairment in Lumbar Degenerative Spine Disease: The Timed-Up-and-Go (TUG) Test

34. Performance‐based damage assessment of low‐rise reinforced concrete buildings

35. A study on pushover analyses of reinforced concrete columns

36. Experimental study of as-built and composite materials retrofitted reinforced concrete columns

38. Genetic variation between hybrid (Labeo rohita ♂, Cirrhinus mrigala ♀ and Labeo rohita) by RAPD marker

39. Culturally adapted psychoeducation for bipolar disorder in a low-resource setting: protocol for a multicentre randomized controlled trial

40. Measurement-based care vs. standard care for major depressive disorder in Pakistan: protocol for a randomized control trial

41. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response

42. [Untitled]

45. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI

46. Response of multi-degree-of-freedom structures with sliding supports

47. Impedance control of a teleoperated mini excavator

48. An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma

49. HFSM-Based Software Implementation of Haptic Interactions

Catalog

Books, media, physical & digital resources